Phillip Denny reveals the creative process behind the New York firm’s long-awaited publication, which challenges disciplinary boundaries through its very form.

It’s a way of showing us your skills, personality and potential – we want to see you within the pages. A digital portfolio is simply a digital version of a physical portfolio – the advice about what ...

After having sunk more than a quarter-billion dollars into the 2024 election and then taken a central role in President Donald Trump’s administration, billionaire Elon Musk is demonstrating that ...

For the 21st consecutive year, I've assembled a mock draft ahead of the NFL's Annual Player Selection Meeting. For the first time, you can read it here on NFL.com. My approach is research-driven ...

The company will go private once the deal closes. Paratek touted the buy as a bid to expand its portfolio beyond Nuzyra, a tetracycline antibiotic that the company touts as being effective against ...

Elite members earn 10% to 50% bonus points based on their status tier. To earn Choice Privileges points, you must book directly with Choice Hotels through one of the following channels: the toll-free ...

The Pittsburgh Steelers' association with Ole Miss quarterback Jaxson Dart continues to strengthen by the day. In his latest mock draft for NFL.com, Daniel Jeremiah had Pittsburgh selecting Dart ...

The first week of NFL free agency is coming to a close, with every team addressing needs and bolstering its roster ahead of the 2025 NFL Draft. And these past few days had it all. You had the ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Michael is a full-time senior editor of investing and trading products for ...

The Seattle Seahawks haven't addressed the offensive line in free agency. General manager John Schneider recently offered a lengthy explanation, admitting the team missed on higher-end targets.

AstraZeneca bought Belgian biotech company EsoBiotec in a deal valued at up to $1 billion, to expand its cell-therapy portfolio. The British pharma company said Monday that it will pay $425 ...